Lupin to divest its Japanese injectables biz to Neopharma group

"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo ALA Co Ltd. The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin," Lupin said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2Pb3DpI